Coldpine is shutting down on November 24, 2026. Account data will be deleted after that date. Questions: hello@coldpine.io
 

Richard Blumenthal Stock Trades

U.S. Senator · D · CT

Disclosures through Oct 26

Every stock trade Richard Blumenthal has disclosed under the STOCK Act, parsed by Coldpine. Informational only, sourced from public congressional filings. Not investment advice.

Sample · the intelligence layer

Coldpine signal scoreA 0-1 composite from four weighted factors: disclosure speed, trade size, cluster activity (multiple members buying the same name), and the member’s track record. ≥ 0.65 is the high-score tier; ≥ 0.50 is moderate. Trades from trust-managed members are penalized (× 0.2 multiplier). It’s research, not a recommendation.

Richard Blumenthal · Bought · Sep 11 · $250K–$500K

0.69HIGH
Disclosure speedx 0.250.60
Trade sizex 0.251.00
Cluster activityx 0.150.00
Track recordx 0.350.82

Every disclosed trade in the database gets this treatment: a four-factor score and a written read from Coldpine’s AI-based analysis. Informational only, not investment advice. Create a free account for every scored trade →

Follow Richard Blumenthal

Get an email the moment Richard Blumenthal discloses a new trade. Free, no card, no spam.

Follow free →
553
Disclosed trades
300
Buys
253
Sells
4
Unique tickers

Most-traded tickers

Disclosure record

26
Median days to disclose
35
Senate median
0.0%
Disclosed after 45 days
44
Longest gap, days

Richard Blumenthal has 552 trades on record with both a trade date and a disclosure date. The median one was disclosed 26 days after the trade, against a median of 35 days across the Senate. Of the 171 members with three or more dated trades, 84 have a longer median.

None of those trades was disclosed more than 45 days after it was made, the STOCK Act's reporting window (across the Senate, 42.5% were). Dated trades on record run from Dec 16, 2025 to Oct 7, 2026.

By the owner field on each report, every one of the 553 trades is reported as a spouse's.

Lag is the disclosure date minus the trade date, from the filing itself. Trades with a missing or implausible date (outside 0 to 1,000 days) are left out of the lag figures. How every member compares: the STOCK Act late-filer study; how the data is built: methodology.

Filings all 11All filings, newest first

Recent disclosed trades

DateTickerAssetTypeAmount
Oct 7—
MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership
buy$1K–$15K
Oct 7—
MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership
buy$1K–$15K
Oct 7—
MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership
buy$100K–$250K
Oct 7—
MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership
buy$50K–$100K
Oct 7—
MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership
buy$15K–$50K
Oct 7—
MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership
buy$15K–$50K
Oct 7—
MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership
buy$1K–$15K
Oct 7—
MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership
buy$1K–$15K
Oct 7—
MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership
buy$15K–$50K
Sep 24—
ZdP Investments Fund I, LP Company: ZdP Investments Fund I, LP (Palo Alto, CA) Description: Private Equity Fund
buy$15K–$50K
Sep 23—
ZdP Investments Fund I, LP Company: ZdP Investments Fund I, LP (Palo Alto, CA) Description: Private Equity Fund
buy$1K–$15K
Sep 23—
ZdP Investments Fund I, LP Company: ZdP Investments Fund I, LP (Palo Alto, CA) Description: Private Equity Fund
buy$1K–$15K
Sep 23STLN
Starling Oncology, Inc. - Common Stock
sell$1K–$15K
Sep 23STLN
Starling Oncology, Inc. - Common Stock
sell$1K–$15K
Sep 22STLN
Starling Oncology, Inc. - Common Stock
sell$15K–$50K
Sep 22STLN
Starling Oncology, Inc. - Common Stock
sell$1K–$15K
Sep 22STLN
Starling Oncology, Inc. - Common Stock
sell$15K–$50K
Sep 22STLN
Starling Oncology, Inc. - Common Stock
sell$15K–$50K
Sep 22STLN
Starling Oncology, Inc. - Common Stock
sell$1K–$15K
Sep 21—
MH Built to Last LLC Company: MH Built to Last LLC (New York, NY) Description: Partnership
buy$1K–$15K

Showing 20 of 553 disclosed trades.

Sign up free for the full history, signal scores, the price-vs-trades chart, and Coldpine's read (the AI narrative on each trade).

Create a free account

From Coldpine Research

Data sourced from public STOCK Act disclosures. Coldpine is a publisher of intelligence on congressional disclosures, not an investment adviser. See full history and scores, free with an account →